Results 21 to 30 of about 30,350 (261)

Biopharmaceutics

open access: yes, 2023
Biopharmaceutics, in connection with pharmacokinetics, is the field that investigates and describes everything that happens with a medicinal product and the active substance between the moment of administration, the moment it exerts its action and the moment it is eliminated from the body. Biopharmaceutics connects the physico-chemical properties of an
Frijlink, Henderik   +3 more
openaire   +3 more sources

SAFETY OF BIOLOGICAL PREPARATIONS AND SMALL MOLECULES. ARE THERE ANY DIFFERENCES?

open access: yesПедиатрическая фармакология, 2013
A considerable number of biopharmaceuticals have recently been introduced into clinical practice. Their role is becoming more and more important in managing various diseases, including incapacitating and life-threatening diseases.
A. S. Kolbin, A. V. Kharchev
doaj   +1 more source

Current situation and future development of the biopharmaceutical industry in China: A mixed-method study

open access: yesFrontiers in Pharmacology, 2022
Introduction: The biomedical industry has grown significantly both globally and in China; however, there are still challenges. This study aimed at evaluating the biopharmaceutical sector of China, in terms of ability to innovate, current sales volume ...
Ruomeng Yang   +25 more
doaj   +1 more source

IMPROVING LAND MANAGEMENT AND PRODUCTIVITY OF CARDAMOM (AMOMUM COMPACTUM) BASED AGROFORESTRY SYSTEM FOR SUPPLY OF ANTI COVID 19 BIOPHARMACEUTICAL RAW MATERIALS [PDF]

open access: yesRussian Journal of Agricultural and Socio-Economic Sciences, 2022
The aim of the study was to examine the benefit of combination of organic (manure) and an organic fertilizer (NPK) along with the use of biofertilizer to improve cardamon growth and performance as Covid-19 biopharmaceutical raw material.
Reziq M.   +3 more
doaj  

Characterization and Value Assignment of a Monoclonal Antibody Reference Material, NMIJ RM 6208a, AIST-MAB

open access: yesFrontiers in Molecular Biosciences, 2022
Monoclonal antibodies have been established as the largest product class of biopharmaceuticals. Since extensive characterization is required for development and quality control of monoclonal antibody, a widely available reference material (RM) is needed.
Tomoya Kinumi   +9 more
doaj   +1 more source

Environnement politique et réglementaire des pharmacultures au Canada : la contamination pharmaceutique à l’horizon ?

open access: yesVertigO, 2009
During the years 1980’s, the Canadian government decided to stimulate the development of biotechnologies in order to become a leader in this sector.
Marie-Hélène Bacon
doaj   +1 more source

Hybrid modeling for biopharmaceutical processes: advantages, opportunities, and implementation

open access: yesFrontiers in Chemical Engineering, 2023
Process models are mathematical formulations (essentially a set of equations) that try to represent the real system/process in a digital or virtual form.
Harini Narayanan   +5 more
doaj   +1 more source

A case report of telitacicept in the treatment of immunocompromised and refractory lupus nephritis

open access: yesFrontiers in Immunology
Lupus nephritis (LN) is a manifestation of kidney damage in systemic lupus erythematosus and is more common in Asian populations. The standard-of-care (SOC) for LN includes antimalarials, glucocorticoids, and immunosuppressants.
Yongda Lin   +3 more
doaj   +1 more source

Study of firm-level strategic alliances drivers; case study Pharmaceutical industry [PDF]

open access: yesپژوهش‌های مدیریت عمومی, 2015
Commercialization is one of the essential element for development in The biotechnology industry. Nowadays Successful Commercialization  is critical for surviving in the competitive markets.
doaj   +1 more source

Bioengineering of rFVIIa Biopharmaceutical and Structure Characterization for Biosimilarity Assessment

open access: yesBioengineering, 2018
Eptacog alfa (NovoSeven®) is a vitamin K-dependent recombinant Factor VIIa produced by genetic engineering from baby hamster kidney (BHK) cells as a single peptide chain of 406 residues.
Othman Montacir   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy